Raffles Hospital Shanghai
Raffles Hospital Shanghai: A Premium Comprehensive Healthcare Provider Offering “Full-Cycle Health Management” at International Standards
I. Hospital Overview
Raffles Hospital Shanghai is a Grade III general hospital approved by the Shanghai Municipal Health Commission. Jointly established by Singapore's Raffles Medical Group and domestic medical teams, it commenced operations in 2003. Guided by the core principle of “International Standards, Local Care,” the hospital upholds Raffles Medical Group's patient-centered philosophy. As one of China's earliest high-end private hospitals accredited by the Joint Commission International (JCI), it stands as a benchmark for international healthcare services in the Yangtze River Delta region.
Located at 100 Century Avenue, Pudong New Area, Shanghai (near the Shanghai World Financial Center), adjacent to the Lujiazui Financial and Trade Zone, the hospital spans approximately 80,000 square meters. It offers over 400 beds and treats more than 100,000 patients annually, with 35% being expatriates and high-net-worth individuals from China. The hospital is equipped with internationally standardized laminar flow operating rooms, hybrid operating rooms (DSA+MRI), intensive care units (ICU), and VIP wards. It has introduced cutting-edge medical equipment and management expertise from Singapore, the United States, Germany, and other countries. Dedicated to providing individuals and families with comprehensive medical services spanning “prevention-diagnosis-treatment-rehabilitation-long-term management,” Raffles Hospital Shanghai strives to build an international medical brand characterized by “safety, precision, and warmth.”
II. Technical Advantages: Precision Integration of International Standards and Local Needs
Raffles Hospital Shanghai's core competitiveness stems from the deep integration of “international medical standards + Chinese patient needs,” achieving domestic leadership particularly in minimally invasive surgery, cardiovascular diseases, comprehensive cancer treatment, and premium health management.
• Minimally Invasive Surgical Techniques:
The hospital comprehensively performs minimally invasive procedures, including laparoscopic, thoracoscopic, and arthroscopic surgeries. Equipped with advanced systems like the German Karl Storz 4K ultra-high-definition laparoscopy system and the American Stryker arthroscopy system, it achieves “Japanese-style minimally invasive” standards: incisions of just 3-5mm, blood loss <50ml, and discharge within 24 hours post-surgery. For instance, the Gastrointestinal Surgery Department's “3D Laparoscopic Gastric Cancer Radical Resection” reduces trauma by 70% compared to traditional open surgery and improves 5-year survival rates by 15%. The Orthopedic Department's “Minimally Invasive Total Joint Replacement” achieves a postoperative pain score (VAS) of only 2-3 points (compared to approximately 5-7 points for traditional procedures).
• Precision Cardiovascular Diagnosis and Treatment:
The Cardiovascular Department features a globally leading Philips Ingenia 3.0T MRI-DSA hybrid operating room, enabling real-time fusion of “interventional + imaging” capabilities. This facilitates high-complexity procedures such as chronic total occlusion (CTO) and left main bifurcation lesions, achieving over 98% success rates with complication rates below 1%. The team pioneered advanced techniques, including “biodegradable stent implantation” and " coronary atherectomy," among other cutting-edge techniques. The hospital ranks first among foreign-invested hospitals in Shanghai for bioabsorbable stent implantations.
• Comprehensive Cancer Care:
The Cancer Center collaborates with MD Anderson Cancer Center to deliver multidisciplinary team (MDT) care, offering full-cycle treatment plans integrating surgery, radiotherapy, targeted therapy, and immunotherapy. Equipped with Varian TrueBeam linear accelerators (supporting volumetric modulated arc therapy, VMAT) and PET-CT (Biograph Vision 600), the center achieves internationally advanced 5-year survival rates for early-stage solid tumors like lung and breast cancer (e.g., >85% for early-stage lung cancer).
• Premium Health Management:
The Health Management Center adopts Singapore's “Preventive Medicine Model,” offering a trinity of services: “Genetic Testing + Imaging Screening + Functional Assessment.” This covers early cancer screening (e.g., low-dose spiral CT for lung cancer, mammography + ultrasound for breast cancer), cardiovascular risk assessment (e.g., Holter monitoring, arterial stiffness testing), and chronic disease management (e.g., continuous glucose monitoring for diabetes). Customized health management packages for corporate executives and expatriates achieve a 40% higher rate of meeting health targets compared to standard checkups.
III. Leading Specialties: A “Multidisciplinary Collaborative Network” Centered on International Standards
The hospital pursues a development strategy of “comprehensive care with strong specialty focus,” prioritizing the following core specialty clusters:
1. Cardiovascular Medicine and Cardiac and Great Vessel Surgery:
Cardiovascular Medicine operates dedicated centers for chest pain, atrial fibrillation, and heart failure, performing over 3,000 interventional procedures annually; Cardiac and Great Vessel Surgery performs high-complexity procedures including Transcatheter Aortic Valve Implantation (TAVI) and Minimally Invasive Valve Repair, enabling patient discharge within 3 days post-surgery with a 1-year survival rate exceeding 95%. Led by Dr. Lim Wei Chen (Professor Lin Weicheng), former Director of the Heart Center at Singapore's Raffles Medical Group, the team specializes in treating complex coronary artery disease and structural heart conditions.
2. Comprehensive Oncology Department:
For lung cancer, breast cancer, gastrointestinal tumors, and others, we offer a multidisciplinary team (MDT) model combining “surgery + radiotherapy + targeted therapy + immunotherapy.” Collaborating with Pathology, we conduct dynamic monitoring via “liquid biopsy (ctDNA)” to adjust treatment plans in real time. For patients resistant to PD-1/PD-L1 inhibitors, we conduct cutting-edge clinical trials such as “bispecific antibodies” and " CAR-T cell therapy," achieving a 30% higher response rate than conventional approaches.
3. Obstetrics, Gynecology, and Reproductive Medicine:
Offers comprehensive pregnancy management (including high-risk pregnancy monitoring), pain-free delivery (100% spinal anesthesia coverage), and assisted reproductive services (AI with husband/donor sperm, IVF). Through collaboration with Singapore's KK Women's and Children's Hospital, IVF success rates consistently exceed 55% (compared to China's national average of approximately 40%), with pregnancy rates for women aged 35 and older increased by 20%.
4. International Healthcare and Cross-Border Health Management:
Serving expatriates in China and cross-border healthcare seekers, we provide overseas medication procurement, international referrals (in partnership with Mayo Clinic, USA, and Cancer Institute Hospital, Japan), and multilingual medical record translation. Our “International Vaccination Clinic” offers over 20 vaccines, including HPV, influenza, and shingles, meeting WHO and international vaccination standards.
IV. Core Departments and Collaborative Service System
The hospital has established a comprehensive service network spanning “screening-diagnosis-treatment-rehabilitation-management.” Core departments include:
• Outpatient Department: Features general practice, internal medicine (specializing in cardiovascular/respiratory/gastroenterology), surgery (general/orthopedic/urology), obstetrics and gynecology, pediatrics, dermatology, and other routine departments. Supports medical insurance/commercial insurance settlements with an annual outpatient volume exceeding 80,000 visits.
• Inpatient Department: Divided into cardiovascular, oncology, surgical, and VIP wards (single rooms/suites) with dedicated nursing units to accommodate high-end patient privacy requirements.
• Surgical Center: Features eight Class 100 laminar flow operating rooms equipped with the Da Vinci Xi surgical robot (for minimally invasive urological and gastrointestinal surgeries), performing over 2,500 procedures annually.
• Medical Imaging Center: Equipped with Siemens Magnetom Prisma 3.0T MRI (brain functional imaging resolution 0.5mm), GE Revolution CT (low-dose lung nodule screening), and PET-CT (Biograph Vision 600, early metastasis detection rate >90%).
• Health Management Department: Provides annual health assessments, executive health management (customized physicals + stress management), and comprehensive chronic disease management (e.g., diabetes, hypertension), serving over 30 enterprises annually.
V. Medical Equipment: World-Class Devices Empowering Precision Diagnosis and Treatment
The hospital's equipment configuration meets international top-tier standards, with all core devices certified by both CE and NMPA. These include:
• Philips Ingenia 3.0T MRI-DSA Hybrid Operating Room: A globally leading integrated “MRI + Angiography” system enabling real-time MRI scanning during interventional procedures. This allows precise assessment of lesion extent, boosting surgical success rates by 20%.
• Varian TrueBeam Linear Accelerator: Supports VMAT, SBRT, and other technologies with beam accuracy down to 0.1mm. Single-session treatment for early-stage lung cancer takes only 15 minutes, achieving 95% local control rates.
• German Karl Storz 4K Ultra-HD Laparoscopic System: Delivers 3D stereoscopic visualization with 10x magnification, enabling clear identification of microvascular structures surrounding tumors. Gastrointestinal tumor surgeries achieve <50ml blood loss.
• Medtronic Continuous Glucose Monitoring System (CGM): Real-time glucose fluctuation monitoring (every 5 minutes) with data synced to mobile apps, enabling precise glycemic control for diabetes patients and boosting HbA1c target achievement rates by 30%.
VI. International Patient Services: Seamless Global Healthcare Experience
As a JCI-accredited hospital, Raffles Hospital Shanghai provides international patients with comprehensive, multilingual, customized services covering the entire treatment journey:
• Language Support: Professional interpreters fluent in 10 languages, including English (UK/US/AU/CA), Japanese, and Korean. 40% of our physician team holds international medical credentials (e.g., USMLE certification, UK GMC registration), enabling direct communication in English, Japanese, or Korean.
• Direct Billing with International Insurers: Partnering with over 60 global insurer, including UnitedHealthcare (US), Bupa (UK), MSH (Japan), and AXA (France), we facilitate direct payment for outpatient visits, hospital stays, surgeries, and medications, covering over 100 countries worldwide.
• Streamlined Care Access: Dedicated appointment channels for international patients (official website/WeChat account/hotline), airport/high-speed rail station pickup service (Pudong/Hongqiao hubs only), and comprehensive patient navigation assistance for registration, testing, and medication pickup—average wait time <30 minutes.
• Telemedicine: Established remote consultation systems with Mayo Clinic (USA), Raffles Medical Centre (Singapore), and Tokyo Metropolitan Hospital (Japan). Patients receive second opinions from international specialists with video consultation response times <24 hours.
• Cultural Adaptation Services: Provide international-friendly wards for foreign patients (featuring private bathrooms, Wi-Fi, and religious amenities), customized meals (halal, vegetarian, kosher), and holiday observances (e.g., Christmas, Eid al-Fitr).
VII. International Patient Testimonials: “Global Patient Reputation for Expertise and Warmth”
• Emily (45, breast cancer, USA): "I was diagnosed with early-stage breast cancer in New York, where my doctor recommended a total mastectomy. At Raffles, the breast surgery team thoroughly explained the ‘breast-conserving surgery + targeted therapy’ plan in English. Post-operative pathology showed negative margins! The radiation oncologist customized precise radiotherapy for me. Now my breast appearance is virtually unchanged. Thank you for the precision and warmth here!"
• Japanese Patient Yuki (32, Infertility): "My husband and I have worked in Shanghai for years, always hoping for a baby. Raffles' Reproductive Medicine Center uses the same technology as Singapore's KK Hospital, and our IVF succeeded on the first attempt! Nurses reminded me daily in Japanese about medication and even taught me prenatal yoga—so thoughtful."
• Australian patient Michael (68, coronary heart disease): "I was attending a meeting in Lujiazui when symptoms struck. An ambulance reached Raffles within 10 minutes. The Chest Pain Center team completed angiography and stent placement within 20 minutes. Post-procedure, I received 24-hour dedicated care in the ICU. My heart function has now fully recovered—Raffles saved my life!"
VIII. Contact Information, Address & Transportation Routes
Hospital Address: 100 Century Avenue, Pudong New Area, Shanghai (near Shanghai World Financial Center)
Telephone: 021-5033 8888 (Main Switchboard); 400-920-5888 (International Patient Hotline)
Transportation Routes:
• Subway: Take Line 2 or Line 14 to “Lujiazui Station” (Exit 6), then walk 5 minutes.
• Bus: Routes 81, 82, 85, 795 to “Lujiazui Huanlu Mingshang Road Station,” 3-minute walk.
• Driving: Underground parking available (Level B2). Present your appointment confirmation for 3 hours of complimentary parking (additional hours charged at ¥15/hour).
Conclusion
Raffles Hospital Shanghai, guided by the principle of “International Standards, Local Care,” seamlessly integrates the global resources of Singapore's Raffles Medical Group with the specific needs of Chinese patients. We continuously drive innovation and advancement in premium healthcare. Whether in minimally invasive surgery, cardiovascular treatment, comprehensive cancer management, or international patient services, the hospital remains committed to its mission: “Ensuring every patient receives superior medical care.” We strive to become a benchmark for premium healthcare in the Yangtze River Delta region and across China.
Document dated 2025-09-15 11:26 Modify